Welcome to the website of the
Southwest Virginia MS Support Group

 

 

 

Devic's Syndrome

SOURCE: Multiple Websites

 

 

 

 

Devic's support on Google Groups

 

Welcome to Devic's support. Support and information for patients with Devic's / NMO, their caregivers and friends. We also welcome all researchers and clinicians. Read member stories, share treatment experiences and post questions to other members from around the World.  Just click Devic's support.

 

This is mainly from Mult-Sclerosis.org

but pages and popUps have where they came from.

 

What is Devic's Syndrome?

Devic's syndrome (also known as Devic's disease and Neuromyelitis Optica) is a rare, chronic, inflammation  and demyelinating disease of the central nervous system (CNS) which resembles Multiple Sclerosis in several ways and is considered a special form of multiple sclerosis (MS) with a severe and rapid course.

 

Devic's disease is characterized by attacks of acute optic neuritis (ON), usually in both eyes (bilateral or on both sides of the body or head).  At the same time or within a few days, weeks or occasionally months, the ON is followed by severe transverse myelopathy (TM) - acute inflammation of the spinal cord. However, in about 20% of cases, TM can precede the ON.

 

In Devic's syndrome, the fatty sheath that protects these nerves is lost. Individuals may experience vision impairment and various degrees of paralysis, as well as incontinence. The disorder is closely linked with MS and lupus, but usually appears before any symptoms of MS are noted. If an isolated disease episode affecting the spinal cord and optic nerve occurs after an infection or common cold, it is considered a post-infectious acute demyelinated encephalomyelitis (ADE) rather than Devic's syndrome.

 

Optic neuritis in Devic's is often retrobulbar (not visible on back of the eye through an opthalmoscope). Recovery from attacks of Devic's disease is typically poorer than remissions from Relapsing Remitting Multiple Sclerosis but the relapses are usually less frequent than is typical in MS.

The symptoms of Devic's disease include marked loss of vision in both eyes (optic neuritis) followed by numbness,muscle weakness, spasticity, incoordination, ataxia, urinary, bowel, sexual and autonomic dysfunction in parts of the trunk and limbs served by nerves exiting the spine below the spinal lesions.

 

Neurologists argue as to whether Devic's syndrome is a completely different disease to MS or whether it a variant of it. Many authors consider Devic's syndrome to be a variant of post-viral Acute Disseminated Encephalomyelitis (ADEM) perhaps related to the varicella zoster virus.
 

Other believe that, like MS, Devic's disease is an autoimmune condition.

 

The most obvious difference between the two is that Devic's typically attacks the optic nerve chiasma, optic tract, and spinal cord - usually bilaterally - whereas MS lesions can be anywhere in the CNS white matter albeit with a preference for the optic nerve, brainstem, corpus callosum and periventricular regions.

 

Is there any treatment?

There is currently no standard treatment for Devic's syndrome. Generally, treatment is symptomatic and supportive. Corticosteroids may be prescribed. Treatment for ADE may include corticosteroids, intravenous immunoglobulin, and intravenous methylprednisolone

 

What is the prognosis?

Devic's syndrome is fatal in many patients. Some ADE patients achieve complete or nearly complete recovery while others may have residual deficits. Some severe cases of ADE may be fatal.

 

What research is being done?

The NINDS supports an extensive research program of basic studies to increase understanding of how the nervous system works. A major goal of this research is to develop methods for repairing damaged nerves and restoring full use and strength to injured areas.

 

More stats:
 

Very high morbidity.

 

 

Sixty per cent of all Devic's NMO patients will indeed have brain lesions.

 

 

50% permanently blind in at least one eye within five years.  (Often bilaterally)

 

 

50% paralyzed in at least one limb within the same time frame.  (Often more.)

 

 

33% mortality within the first five years.

 

 

80-90% of cases are relapsing.

 

 

The majority are women.

 

 

No standard treatment protocol.  Unlike MS immunomodulation does not work for the NMO patient, intense immunosuppresion is the key.

 

 

Principle distinguishing features between
Devic's Syndrome and Multiple Sclerosis

Feature

Devic's Syndrome

Multiple Sclerosis

Clinical involvement beyond the spinal cord and optic nerves

Rarely

Usually

Attacks are bilateral 

Usually

Rarely

Oligoclonal bands in Cerebrospinal Fluid (CSF)

Rarely

In over 90% of cases

White matter lesions on brain MRI

Rarely and usually resolving

Usually

Transverse myelitis as presentation

In 20% of cases

Rarely

Swelling and signal change on MRI

Often

Less Often than Devic's

Tissue destruction and cavitation

More than MS

Less than Devic's

Protein content in CSF

Higher than MS

Lower than Devic's

 

 

Neuromyelitis Optica (NMO)

SOURCE: my.clevelandclinic.org/

 

Neuromyelitis optica is an uncommon, idiopathic, demyelinating syndrome of the central nervous system that preferentially affects the optic nerves and spinal cord. It frequently is misdiagnosed as severe multiple sclerosis, but usually is readily distinguished from multiple sclerosis in fully developed cases because of its severity, typical magnetic resonance imaging (MRI) findings (normal brain MRI longitudinally extensive lesions on spinal cord MRI), and cerebrospinal fluid analysis (polymorphonuclear pleocytosis and absence of oligoclonal banding). A serum auto-antibody marker, NMO-IgG, is highly specific for the disorder.

 

Most patients have relapsing disease, and natural history studies confirm early and severe disability. We treat acute myelitis and optic neuritis exacerbations with parenteral corticosteroids and use rescue plasmapheresis for severe, refractory attacks. Immunomodulatory drugs used for typical multiple sclerosis seem ineffective for relapse prevention. We recommend systemic immunosuppression, usually with azathioprine and oral cortico-steroids, for most patients. Fulminant disease and breakthrough disease may respond to other forms of humoral immunotherapy such as rituximab.

 

NMO is a disorder of the central nervous system which has many features in common with multiple sclerosis. It is also known as Devic's disease. Traditionally, it has been defined as a syndrome where patients had a combination of transverse myelitis and optic neuritis, often with relatively severe symptoms in both the optic nerves and the spinal cord.

 

Other forms of Multiple Sclerosis are:

Benign Multiple Sclerosis

Devic's Syndrome

 

The following forms are the four Internationally recognized forms of MS

Relapsing Remitting Multiple Sclerosis (RRMS)
Secondary Progressive Multiple Sclerosis (SPMS)
Primary Progressive Multiple Sclerosis (PRMS)
Progressive Relapsing Multiple Sclerosis (PRMS)